Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Jun;40(6):1555–1557. doi: 10.1128/aac.40.6.1555

Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity.

J Wang 1, S Eriksson 1
PMCID: PMC163369  PMID: 8726039

Abstract

The capacity of recombinant human cytosolic thymidine kinase (TK1) and bovine mitochondrial thymidine kinase (TK2) to phosphorylate the antiviral analogs 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) and 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) has been analyzed. The Vmax/Km ratios for FIAU and FMAU with TK2 are about 30% of that for deoxythymidine, while the corresponding values for TK1 are 2 and 5%, respectively. Thus, these two analogs are more efficient substrates for TK2 than for TK1, which may be part of the explanation for the mitochondrial toxicity associated with FIAU during treatment of hepatitis B infection.

Full Text

The Full Text of this article is available as a PDF (261.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnér E. S., Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol Ther. 1995;67(2):155–186. doi: 10.1016/0163-7258(95)00015-9. [DOI] [PubMed] [Google Scholar]
  2. Bradshaw H. D., Jr, Deininger P. L. Human thymidine kinase gene: molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells. Mol Cell Biol. 1984 Nov;4(11):2316–2320. doi: 10.1128/mcb.4.11.2316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cheng Y. C., Dutschman G., Fox J. J., Watanabe K. A., Machida H. Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob Agents Chemother. 1981 Sep;20(3):420–423. doi: 10.1128/aac.20.3.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cui L., Yoon S., Schinazi R. F., Sommadossi J. P. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells. J Clin Invest. 1995 Feb;95(2):555–563. doi: 10.1172/JCI117698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Drew W. L., Miner R., King D. Antiviral activity of FIAU (1-[2'deoxy-2'-fluoro-1-beta-D-arabinofuranosyl]-5-iodo-uridine) on strains of cytomegalovirus sensitive and resistant to ganciclovir. J Infect Dis. 1991 Jun;163(6):1388–1389. doi: 10.1093/infdis/163.6.1388. [DOI] [PubMed] [Google Scholar]
  6. Eriksson S., Kierdaszuk B., Munch-Petersen B., Oberg B., Johansson N. G. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs. Biochem Biophys Res Commun. 1991 Apr 30;176(2):586–592. doi: 10.1016/s0006-291x(05)80224-4. [DOI] [PubMed] [Google Scholar]
  7. Eriksson S., Xu B., Clayton D. A. Efficient incorporation of anti-HIV deoxynucleotides by recombinant yeast mitochondrial DNA polymerase. J Biol Chem. 1995 Aug 11;270(32):18929–18934. doi: 10.1074/jbc.270.32.18929. [DOI] [PubMed] [Google Scholar]
  8. Fourel I., Li J., Hantz O., Jacquet C., Fox J. J., Trépo C. Effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks. J Med Virol. 1992 Jun;37(2):122–126. doi: 10.1002/jmv.1890370209. [DOI] [PubMed] [Google Scholar]
  9. He Q., Skog S., Wang N., Eriksson S., Tribukait B. Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Eur J Cell Biol. 1996 Jun;70(2):117–124. [PubMed] [Google Scholar]
  10. Jansson O., Bohman C., Munch-Petersen B., Eriksson S. Mammalian thymidine kinase 2. Direct photoaffinity labeling with [32P]dTTP of the enzyme from spleen, liver, heart and brain. Eur J Biochem. 1992 Jun 1;206(2):485–490. doi: 10.1111/j.1432-1033.1992.tb16951.x. [DOI] [PubMed] [Google Scholar]
  11. Lewis W., Dalakas M. C. Mitochondrial toxicity of antiviral drugs. Nat Med. 1995 May;1(5):417–422. doi: 10.1038/nm0595-417. [DOI] [PubMed] [Google Scholar]
  12. Lewis W., Meyer R. R., Simpson J. F., Colacino J. M., Perrino F. W. Mammalian DNA polymerases alpha, beta, gamma, delta, and epsilon incorporate fialuridine (FIAU) monophosphate into DNA and are inhibited competitively by FIAU Triphosphate. Biochemistry. 1994 Dec 6;33(48):14620–14624. doi: 10.1021/bi00252a030. [DOI] [PubMed] [Google Scholar]
  13. Munch-Petersen B., Cloos L., Tyrsted G., Eriksson S. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J Biol Chem. 1991 May 15;266(14):9032–9038. [PubMed] [Google Scholar]
  14. Watanabe K. A., Reichman U., Hirota K., Lopez C., Fox J. J. Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. J Med Chem. 1979 Jan;22(1):21–24. doi: 10.1021/jm00187a005. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES